Insiders · ARDS

Eric Patzer

Director at Aridis Pharmaceuticals, Inc. (ARDS)

Eric Patzer has filed 6 insider reports with the SEC since February 2021, as director at Aridis Pharmaceuticals, Inc. (ARDS). Eric Patzer made no open-market purchases or sales in the last 12 months. In the latest amended filing, on June 28, 2024, Eric Patzer bought 714,286 shares of Aridis Pharmaceuticals, Inc. (ARDS) for $50K at an average of $0.07.

Filings
6
Companies
1
Bought on market
$75K
Sold on market
None

Companies where Eric Patzer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Aridis Pharmaceuticals, Inc. logo
ARDS
Aridis Pharmaceuticals, Inc.
Director884,600$75K$0.10Jun 28, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Patzer with

Questions about Eric Patzer

What is Eric Patzer's role at Aridis Pharmaceuticals, Inc.?
Eric Patzer reports to the SEC as director at Aridis Pharmaceuticals, Inc. (ARDS), according to the latest filing on June 28, 2024.
How many shares does Eric Patzer own?
After the latest filing that states it, Eric Patzer directly owned 884,600 shares of Aridis Pharmaceuticals, Inc. (ARDS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Patzer bought or sold stock recently?
The most recent open-market purchase was on June 24, 2024: bought 714,286 shares of Aridis Pharmaceuticals, Inc. (ARDS) for $50K at an average of $0.07.
How do I get alerts when Eric Patzer files?
Follow Eric Patzer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Patzer (SEC CIK 0001749992). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR